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Abstract In this investigation, the effects on proton leak of
leptin administration to ob/ob mice was measured for liver
mitochondria. We and others have shown that proton leak is
approximately 3 times greater in liver mitochondria from ob/ob
mice compared to lean controls at any given membrane potential.
The results are consistent with obese mammals having higher
lean mass-specific metabolic rates compared to lean controls.
The increase in proton leak rate at any given membrane potential
cannot be explained by the presence of free fatty acids associated
with mitochondria isolated from the obese animals. The
difference in proton leak must therefore represent a real
difference in inner membrane permeability. Acute leptin (OB
protein) administration restores the liver mitochondrial proton
leak rate of ob/ob mice to that of lean controls. There was no
effect on proton leak rate of liver mitochondria from sham-
treated ob/ob mice. These novel results indicate a role for leptin,
either directly or indirectly, in regulating the efficiency of
oxidative phosphorylation.
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1. Introduction
Since the discovery of the ob gene [1] much attention has
been given to the central role played by its product leptin in
regulation of energy metabolism [2^5]. Leptin is a 167 amino
acid hormone expressed in all mammals predominantly by
white adipose tissue (WAT) [1,6]. Leptin expression is en-
hanced under conditions of triglyceride accumulation such
as feeding, increased circulating glucose and insulin levels
and obesity [2^6]. Leptin expression is decreased under con-
ditions of fasting, weight reduction, cold exposure and insulin-
dependent diabetes [2,6]. Its action is mediated via receptors
in the satiety centre in the hypothalamus [3^7].
Ob/ob mice lack functional leptin [1]. They are hyperphagic,
obese, diabetic and infertile. Leptin administration to ob/ob
mice reduces appetite, reduces fat mass, ameliorates the dia-
betic condition and restores fertility, essentially normalising
ob/ob mice to be like their lean counterparts [3^5]. When
leptin binds to its receptors in the hypothalamus a variety
of neuronal pathways have been shown to mediate appetite
suppression [5^7]. Metabolic changes are thought to occur by
activation of the e¡erent sympathetic nervous system and also
by systems as yet not identi¢ed [5]. There is also a body of in
vitro evidence that leptin has direct peripheral e¡ects on en-
ergy metabolism [4,8^10]. There are peripheral receptors for
leptin but they lack JAK-STAT 3 receptor activity, which is
believed to be fundamental to any signal mediated by leptin
[7].
It has long been known that lean mass-speci¢c metabolic
rate is increased in mammals that are obese compared to lean
controls [11,12]. A signi¢cant contributor to resting metabolic
rate is an ine⁄ciency in the process by which mitochondrial
ATP synthesis is coupled to oxygen consumption [13]. This
regulated ine⁄ciency is known as proton leak. The mecha-
nism of the leak is unclear, however there are a variety of
candidates. It is known that di¡usion of protons across phos-
pholipid membrane does occur [14]. More subtle mechanisms
may also be involved such as uncoupling proteins [15,16],
fatty acid £ippases [17] or changes in H/O stoichiometries
[18]. Previous studies have shown that liver mitochondria (iso-
lated and in situ) from rats treated with high doses of thyroid
hormone (T3) have increased proton leak [19^21]. Similarly,
liver mitochondria (isolated and in situ) from rats made com-
pletely hypothyroid, by including propylthiouracil in the
drinking water, have decreased proton leak [19^21]. These
results are consistent with the e¡ects of thyroid hormone on
metabolic rate. In addition, proton leak rates decrease in liver
mitochondria (isolated and in situ) with increasing body mass
[19,22^24]. This is consistent with the knowledge that mass-
speci¢c metabolic rate decreases with increasing body mass.
One might expect therefore that proton leak would be in-
creased in mitochondria from an ob/ob mouse isolated from
a highly metabolic visceral organ such as liver. In addition, we
were interested to see whether the e⁄ciency of oxidative phos-
phorylation was a¡ected in those liver mitochondria isolated
from leptin-treated ob/ob animals.
2. Materials and methods
2.1. Isolation of mitochondria
Mitochondria were isolated according to the procedure of Chappell
and Hansford [25]. Mice were killed by cervical dislocation. Gall
bladders were removed and livers were immediately excised and
placed in a glass beaker containing ice-cold homogenisation bu¡er
composed of 250 mM sucrose, 10 mM tris(hydroxymethyl)aminome-
thane-HCl, pH 7.4, 1 mM ethylene glycol-bis(L-aminoethylether)-
N,N,NP,NP-tetraacetic acid (EGTA). The livers were chopped into
small pieces and the medium in which they were chopped was fre-
quently decanted. The liver pieces were then placed in a Thomas
(Philadelphia, PA, USA) homogeniser with approximately 40 ml
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cold homogenisation medium. The tissue was ruptured using 3 strokes
of a pestle with 0.26 mm clearance followed by 3 strokes of a pestle
with 0.12 mm. Mitochondria were isolated by di¡erential centrifuga-
tion. The homogenised liver was centrifuged at 800Ug for 10 min at
4‡C. The supernatant was centrifuged at 10 000Ug for 10 min and the
pellet resuspended and centrifuged at 10 000Ug for 3 min. Defatted
bovine serum albumin (10 g/l) was either present or absent in the
penultimate centrifugation step and the incubation medium.
2.2. Protein determination
Mitochondrial protein content was determined using the biuret
method [26]. Standards were prepared using bovine serum albumin.
All samples contained sodium deoxycholate (1 g/l) to solubilise pro-
tein associated with the mitochondria.
2.3. Measurement of mitochondrial proton leak and membrane potential
Mitochondria (3 mg protein) were incubated at 37‡C in 3 ml me-
dium containing 120 mM KCl, 5 mM N-2-hydroxyethylpiperazine-NP-
2-ethanesulphonic acid (HEPES)-KOH, pH 7.2 and 1 mM EGTA in
the presence of 7.5 mM succinate (K salt), 5 WM rotenone, nigericin
(100 pmol/mg protein), oligomycin (1 Wg/ml), and 5 WM methyltriphe-
nylphosphonium (TPMP). Proton leak was calculated from the oxy-
gen consumption rate in the presence of excess oligomycin by assum-
ing six protons were pumped (and leaked) per atom of oxygen under
steady-state conditions [27]. The inclusion of the potassium/proton
exchanger, nigericin, in the potassium-based medium converts the
pH gradient across the mitochondrial inner membrane (vpH) to the
electrochemical gradient across the inner membrane (v8). The net
result of nigericin addition is that v8 equals vp. Hence the TPMP
electrode is measuring vp in its entirety. Proton leak kinetics were
determined by simultaneous measurement of oxygen consumption
due to proton leak and membrane potential across the inner mem-
brane in the presence of increasing amounts of malonate (0^10 mM,
K salt). Oxygen consumption was measured using a Clark-type oxy-
gen electrode with a 5 ml chamber. Membrane potential across the
mitochondrial inner membrane was measured using a electrode sensi-
tive to the lipophilic cation TPMP. The electrode was constructed as
previously described [26]. The TPMP electrode was placed through a
specially constructed lid for the Clark-type oxygen electrode. The
binding correction factors were determined as previously described
[27,28]. There was no signi¢cant di¡erence between the TPMP bind-
ing correction factors [mean þ S.E.M. (n)] for lean and obese mice:
lean [0.11 þ 0.07 (3)] and ob/ob [0.09 þ 0.03 (3)] mice, where units are
3 mg protein/Wl and each value is expressed as the mean and standard
error for n separate preparations, each measured in triplicate.
2.4. Leptin administration
Leptin (Amgen Inc., San Diego, CA, USA) was injected intraper-
itoneally once a day for 3 days at 10.00 h at a dose of 10 mg/kg as
used in Pelleymounter et al. [3].
2.5. Materials
Potassium chloride, potassium phosphate, HEPES and magnesium
chloride were from Fisons Chemical Equipment (Loughborough,
UK). [3H]Methyltriphenylphosphonium bromide was obtained from
DuPont New England Nuclear (Boston, MA, USA). 3H2O, 86RbCl
and [14C]sucrose were purchased from Amersham International
(Amersham, Bucks., UK). All other chemicals were purchased from
Sigma-Aldrich (Poole, Dorset, UK). Ob/ob mice were purchased from
Aston University, Birmingham, UK, and were housed in the BioRe-
sources Unit at the University of Dublin. Animals were fed standard
chow ad libitum.
3. Results and discussion
Fig. 1 shows the proton leak kinetics for liver mitochondria
isolated from liver of obese and lean mice. The pro¢le of the
leak kinetics for mitochondria from lean and obese animals is
as expected: there is a non-ohmic relationship between proton
leak and its ‘driving force’ vp [29].
Increased mass-speci¢c metabolic rate has been correlated
with increased proton leak in mitochondria isolated from liver
in studies on thyroid status, body mass and phylogeny [19^
24]. In this study, it was expected that liver mitochondria
isolated from obese mice would have increased proton leak
compared to lean controls. As predicted, when proton leak
rate is compared at any given vp (e.g. 130 mV), the leak rate
is greater (by approximately 3 times) in liver mitochondria
from the ob/ob mice compared to lean controls, observations
similar to our reported preliminary ¢ndings [30] and to those
of Charin et al. [31]. In addition, Table 1 shows that substan-
tial state 4 (in the absence of malonate) membrane potentials
were achieved by all liver mitochondria isolated and that mi-
tochondria from ob/ob and sham-treated ob/ob mice had pro-
ton leak rates which were approximately twice that of leptin-
treated ob/ob and lean mice.
Fig. 2 shows the proton leak kinetics in comparison prep-
arations of liver mitochondria from ob/ob using media with
and without defatted bovine serum albumin. There is no dif-
ference in proton leak rate at any given membrane potential.
In addition, the presence of defatted BSA (in the incubation
medium) could not account for the di¡erences in the state 4
oxygen consumption rates (proton leak rate at static head) in
a comparison of mitochondria from the liver of lean and ob/
ob mice (not shown). It is concluded that the increased proton
leak in liver mitochondria from ob/ob mice compared to lean
controls observed in Fig. 1 was not due to uncoupling by free
Fig. 1. Kinetics of the proton leak for liver mitochondria from lean,
obese, leptin-treated obese and sham-treated obese mice. Mouse liv-
er mitochondria (3 mg) were incubated in a Clark-type oxygen elec-
trode at 37‡C in 3 ml of medium containing 120 mM KCl, 1 mM
EGTA, 1 Wg/mg oligomycin, nigericin (100 pmol/mg) and 5 mM
HEPES adjusted to pH 7.2 with KOH. Five sequential additions of
methyltriphenylphosphonium iodide (TPMPI3) were made to the
chamber of the Clark-type oxygen electrode to facilitate calibration
of the TPMP electrode giving a ¢nal concentration of 5 WM. 7.5
mM succinate (K salt, pH 7.2) was added to initiate oxygen con-
sumption; titration of the membrane potential was with 0^10 mM
malonate (K salt, pH 7.2). The graph shows proton leak kinetics
for mitochondria from lean (E), obese (F), sham (saline)-treated
obese (a) and leptin-treated obese mice (b). Proton leak rate was
calculated from oxygen consumption rate by assuming six protons
were pumped (and leaked) per oxygen atom. All points represent
the mean þ S.E.M. of at least three experiments, each experiment
performed in triplicate or quadruplicate.
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fatty acids associated with the mitochondria from the ob/ob
mice.
Administration of leptin to ob/ob mice has been shown to
reduce fat mass, restore fertility and normalise many of the
other dysfunctions [28,32]. Fig. 1 shows the novel ¢nding that
leptin administration to ob/ob mice reduces proton leak in
liver mitochondria to that measured in lean controls. There
was no e¡ect on proton leak kinetics in sham-treated ob/ob
mice. Clearly, leptin normalised the proton leak in liver mi-
tochondria of ob/ob mice. This observation demonstrates that
leptin, either directly or indirectly (probably via a hypothala-
mic axis), a¡ects energy metabolism at the level of the mito-
chondria, in this case improving the e⁄ciency of liver mito-
chondrial function of the ob/ob mice.
The improvement in e⁄ciency of liver mitochondrial func-
tion may at ¢rst seem inconsistent with the reported increases
in metabolic rate observed following leptin administration to
ob/ob mice [3]. However, increased metabolism following lep-
tin administration probably occurs in tissues other than liver,
such as skeletal muscle. Circumstantial evidence to support
this prediction comes from observations of the expression
patterns of mRNA for uncoupling protein (UCP) 2 and
UCP 3. For example, UCP 2 is expressed in a variety of
tissues including skeletal muscle of normal animals [15] while
UCP 3 is expressed primarily in skeletal muscle [16]. Leptin
administration to mice increases UCP 2 expression in a vari-
ety of tissues [9,32,33] and UCP 3 in skeletal muscle [9]. De-
tectable mRNA for UCP 2 is absent in liver of normal ani-
mals [34] but present in liver of ob/ob mice [31].
If UCP 2 catalyses proton leak in mitochondria then our
observations (i) that proton leak in liver mitochondria is
greater in ob/ob mice compared to lean controls and (ii) that
restoring leptin to ob/ob mice normalises liver mitochondria
proton leak to that of lean controls, are consistent with the
expression pattern of UCP 2.
There is no doubt that the dosage of leptin given in this
study is high (10 mg leptin/kg body mass) and therefore the
study is reminiscent of the studies in which high doses (150 Wg
triiodo-L-thyronine/kg body mass) of thyroid hormone are
given to make rats hyperthyroid [20,21]. However, the e¡ect
of leptin administration to the ob/ob mice on mitochondrial
proton leak is real and follows the predicted trend. Indeed rats
made hyperthyroid have liver mitochondria with increased
leak [19,21] and it may be that leptin and thyroid status are
interlinked.
It is also worth mentioning at this point that there is no
signi¢cant di¡erence in proton leak rate at any given mem-
brane potential in a comparison of isolated liver mitochondria
[35] or mitochondria in situ in hepatocytes (R.K. Porter, J.A.
Buckingham and M.D. Brand, unpublished observation) from
obese and lean Zucker rats. Obese Zucker rats are not leptin-
de¢cient. These observations add weight to the argument that
mitochondrial proton leak in liver is at least in part a function
of leptin status.
Future experiments will determine whether leptin a¡ects
UCP 2 protein expression in liver and other tissues. We also
intend to dissect out whether leptin’s e¡ect on liver mitochon-
drial function is direct or via some central pathway.
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